A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Ditching Invading DNA: Bacteria and archaea protect themselves from invasive foreign nucleic acids through an RNA-mediated adaptive immune system called CRISPR (clustered regularly interspaced short palindromic repeats)/CRISPR-associated (Cas). Jinek et al. (p. 816 , published online 28 June; see the Perspective by Brouns ) found that for the type II CRISPR/Cas system, the CRISPR RNA (crRNA) as well as the trans-activating crRNA—which is known to be involved in the pre-crRNA processing—were both required to direct the Cas9 endonuclease to cleave the invading target DNA. Furthermore, engineered RNA molecules were able to program the Cas9 endonuclease to cleave specific DNA sequences to generate double-stranded DNA breaks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Repurposing bacterial “CRISPR” systems to facilitate RNA-guided cleavage of complementary DNA has revolutionized the field of gene editing in mammalian cells 1–4.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“To realize this promise, the development of CRISPR-Cas9 for genome editing offers a simpler technology that has been adopted widely due to the ease of programming its DNA binding and modifying capabilities.”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recombinant expression and purification of EvoCas9–1 paired with chemically synthesized Evo-generated single guide RNA (sgRNA) exhibited comparable in vitro cleavage activity to SpCas9 paired with the canonical SpCas9 sgRNA”
From Sequence modeling and design from molecular to genome scale with Evo (2024) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cas9 can create DNA cleavage at desired genomic positions that are guided by precise base pairing between sgRNA and DNA, adjacent to a protospacer-adjacent motif (PAM) (Jinek et al., 2012; Cho et al., 2013; Cong et al., 2013; Wang et al., 2016a).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Jinek et al., 2012
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR/Cas9 is a class of ribonucleoprotein complexes formed by a Cas9 protein and a single guide RNA (sgRNA) (Jinek et al., 2012; Cho et al., 2013; Cong et al., 2013; Wang et al., 2016a).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Jinek et al., 2012
Experimental — accuracy not yet measured
31 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III
Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011) · Nature · doi:10.1038/nature09886 · Cited by 2,563
Self-citationSmall CRISPR RNAs Guide Antiviral Defense in Prokaryotes
Brouns, S. J. J., Jore, M. M., Lundgren, M., Westra, E. R., Slijkhuis, R. J. H., Snijders, A. P. L., Dickman, M. J., Makarova, K. S., Koonin, E. V., & van der Oost, J. (2008) · Science · doi:10.1126/science.1159689 · Cited by 2,460
Evolution and classification of the CRISPR–Cas systems
Makarova, K. S., Haft, D. H., Barrangou, R., Brouns, S. J. J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F. J. M., Wolf, Y. I., Yakunin, A. F., et al. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2577 · Cited by 2,331
Self-citationThe CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
Garneau, J. E., Dupuis, M.-È., Villion, M., Romero, D. A., Barrangou, R., Boyaval, P., Fremaux, C., Horvath, P., Magadán, A. H., & Moineau, S. (2010) · Nature · doi:10.1038/nature09523 · Cited by 2,328
Genome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
A TALE nuclease architecture for efficient genome editing
Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1755 · Cited by 2,098
Targeting DNA Double-Strand Breaks with TAL Effector Nucleases
Christian, M., Cermak, T., Doyle, E. L., Schmidt, C., Zhang, F., Hummel, A., Bogdanove, A. J., & Voytas, D. F. (2010) · Genetics · doi:10.1534/genetics.110.120717 · Cited by 1,869
Cited by
Items 701–800 of 1,285
Hu, J., Meyers, R. M., Dong, J., Panchakshari, R. A., Alt, F. W., & Frock, R. L. (2016) · Nature Protocols · doi:10.1038/nprot.2016.043 · Cited by 263
Increased efficiency of targeted mutagenesis by CRISPR/Cas9 in plants using heat stress
LeBlanc, C., Zhang, F., Mendez, J., Lozano, Y., Chatpar, K., Irish, V. F., & Jacob, Y. (2018) · The Plant Journal · doi:10.1111/tpj.13782 · Cited by 262
“for targeted mutagenesis and precise engineering through homologous recombination-based repair of doublestranded DNA (dsDNA) breaks (Jinek et al., 2012; Cong et al., 2013).”
BackgroundMutagenesis in Rice: The Basis for Breeding a New Super Plant
Viana, V. E., Pegoraro, C., Busanello, C., & Costa de Oliveira, A. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.01326 · Cited by 198
Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges
Taha, E. A., Lee, J., & Hotta, A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.013 · Cited by 259
Multi‐input CRISPR / Cas genetic circuits that interface host regulatory networks
Nielsen, A. A., & Voigt, C. A. (2014) · Molecular Systems Biology · doi:10.15252/msb.20145735 · Cited by 256
Elucidating the Role of Effectors in Plant-Fungal Interactions: Progress and Challenges
Selin, C., de Kievit, T. R., Belmonte, M. F., & Fernando, W. G. D. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00600 · Cited by 263
“The CRISPR/Cas9 system has been adapted for use in a number of genome editing applications in both eukaryotes and prokaryotes (Jinek et al., 2012; Cong et al., 2013; Jiang et al., 2013; Doudna and Charpentier, 2014; Nissim et al., 2014; Sander and Joung, 2014).”
BackgroundAdegboye, M. F., Ojuederie, O. B., Talia, P. M., & Babalola, O. O. (2021) · Biotechnology for Biofuels · doi:10.1186/s13068-020-01853-2 · Cited by 250
A tiling-deletion-based genetic screen for cis-regulatory element identification in mammalian cells
Diao, Y., Fang, R., Li, B., Meng, Z., Yu, J., Qiu, Y., Lin, K. C., Huang, H., Liu, T., Marina, R. J., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4264 · Cited by 259
De Ravin, S. S., Li, L., Wu, X., Choi, U., Allen, C., Koontz, S., Lee, J., Theobald-Whiting, N., Chu, J., Garofalo, M., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah3480 · Cited by 258
“CRISPR/Cas9, guided by a single-guide RNA, achieves efficient doublestranded DNA breaks (9, 10).”
BackgroundMemory of viral infections by CRISPR-Cas adaptive immune systems: Acquisition of new information
Fineran, P. C., & Charpentier, E. (2012) · Virology · doi:10.1016/j.virol.2012.10.003 · Cited by 259
“, 2011) and interference with nucleic acids (Garneau et al., 2010; Jinek et al., 2012; Westra et al., 2012).”
BackgroundSelf-citationMiyaoka, Y., Berman, J. R., Cooper, S. B., Mayerl, S. J., Chan, A. H., Zhang, B., Karlin-Neumann, G. A., & Conklin, B. R. (2016) · Scientific Reports · doi:10.1038/srep23549 · Cited by 263
“Two thermal cycling programs were used: (1) step 1, 95 °C for 10 min; step 2, 94 °C for 30 s; step 3, 59 °C for 1 min; repeat steps 2 and 3 39 times; step 4, 98 °C for 10 min with all the steps ramped by 2 °C/s (for RBM20) and (2) step 1, 95 °C for 10 min; step 2, 94 °C for 30 s; step 3, 58 °C for 1 min; step 4, 72 °C…”
MethodMolecular basis of α-thalassemia
Farashi, S., & Harteveld, C. L. (2018) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2017.09.004 · Cited by 227
Quan, J., Langelier, C., Kuchta, A., Batson, J., Teyssier, N., Lyden, A., Caldera, S., McGeever, A., Dimitrov, B., King, R., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz418 · Cited by 261
Revolutions in agriculture chart a course for targeted breeding of old and new crops
Eshed, Y., & Lippman, Z. B. (2019) · Science · doi:10.1126/science.aax0025 · Cited by 263
“Creating targeted genetic variation by CRISPRCas genome editing is a new and powerful addition to the classical exploitation of existing or randomly induced genetic variation for crop improvement (67) (Fig.”
BackgroundYang, H., Ren, S., Yu, S., Pan, H., Li, T., Ge, S., Zhang, J., & Xia, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186461 · Cited by 237
Regulation of phospholipid distribution in the lipid bilayer by flippases and scramblases
Sakuragi, T., & Nagata, S. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00604-z · Cited by 251
“The recent development of CRISPR–Cas9 technology for knockout genes 15 , single-cell RNA sequence technology to examine the gene expression 16 , cryogenic electron microscopy technology 17 and the AlphaFold artificial intelligence program 18 to elucidate or predict the tertiary structures of…”
Targeted genome-modification tools and their advanced applications in crop breeding
Li, B., Sun, C., Li, J., & Gao, C. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-024-00720-2 · Cited by 233
Advances in therapeutic CRISPR/Cas9 genome editing
Savić, N., & Schwank, G. (2016) · Translational Research · doi:10.1016/j.trsl.2015.09.008 · Cited by 257
Piwowarek, K., Lipińska, E., Hać-Szymańczuk, E., Kieliszek, M., & Ścibisz, I. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8616-7 · Cited by 236
“…can be used to introduce stable changes in the genome (knock-out and knock-in), among others, in the genetic modification processes and activation or silencing of selected genes (Jinek et al. 2012; Wiedenheft et al. 2012; Cong et al. 2013; Jiang et al. 2013; Ran et al. 2013; Ousterout et al. 2014).”
BackgroundReal-time observation of DNA recognition and rejection by the RNA-guided endonuclease Cas9
Singh, D., Sternberg, S. H., Fei, J., Doudna, J. A., & Ha, T. (2016) · Nature Communications · doi:10.1038/ncomms12778 · Cited by 263
Self-citationArtificial intelligence for precision medicine in neurodevelopmental disorders
Uddin, M., Wang, Y., & Woodbury-Smith, M. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0191-0 · Cited by 248
Steinert, J., Schiml, S., Fauser, F., & Puchta, H. (2015) · The Plant Journal · doi:10.1111/tpj.13078 · Cited by 255
“requires different PAMs and a unique sgRNA compared with SpCas9 (Jinek et al., 2012; Esvelt et al., 2013; Kleinstiver et al., 2015; Ma et al., 2015; Ran et al., 2015).”
BackgroundYuan, C., Tian, T., Sun, J., Hu, M., Wang, X., Xiong, E., Cheng, M., Bao, Y., Lin, W., Jiang, J., et al. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.9b05597 · Cited by 257
Structural basis of CRISPR–SpyCas9 inhibition by an anti-CRISPR protein
Dong, D., Guo, M., Wang, S., Zhu, Y., Wang, S., Xiong, Z., Yang, J., Xu, Z., & Huang, Z. (2017) · Nature · doi:10.1038/nature22377 · Cited by 259
Zhang, H., Qin, C., An, C., Zheng, X., Wen, S., Chen, W., Liu, X., Lv, Z., Yang, P., Xu, W., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01431-6 · Cited by 247
Streptococcus thermophilus CRISPR-cas9 systems enable specific editing of the human genome
Müller, M., Lee, C. M., Gasiunas, G., Davis, T. H., Cradick, T. J., Siksnys, V., Bao, G., Cathomen, T., & Mussolino, C. (2016) · Molecular Therapy · doi:10.1038/mt.2015.218 · Cited by 254
Genome editing in cotton with the CRISPR/cas9 system
Gao, W., Long, L., Tian, X., Xu, F., Liu, J., Singh, P. K., Botella, J. R., & Song, C. (2017) · Frontiers in Plant Science · doi:10.3389/fpls.2017.01364 · Cited by 254
“Reverse genetics approaches such as gene silencing have been widely used by the scientific community to elucidate gene function and decipher regulatory mechanisms and metabolic pathways (Carroll, 2011; Jinek et al., 2012; Sun et al., 2016).”
BackgroundA Broad-Spectrum Inhibitor of CRISPR-Cas9
Harrington, L. B., Doxzen, K. W., Ma, E., Liu, J.-J., Knott, G. J., Edraki, A., Garcia, B., Amrani, N., Chen, J. S., Cofsky, J. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.037 · Cited by 262
“The unique ability of AcrIIC1 to trap Cas9 on its DNA target in a catalytically inactivate state effectively transforms the wild-type Cas9 into its catalytically inactive variant dCas9 (Jinek et al., 2012).”
BackgroundInfluentialSelf-citationBlue-Light Receptors for Optogenetics
Losi, A., Gardner, K. H., & Möglich, A. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00163 · Cited by 255
(2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00098-7 · Cited by 250
Long, C., Li, H., Tiburcy, M., Rodriguez-Caycedo, C., Kyrychenko, V., Zhou, H., Zhang, Y., Min, Y.-L., Shelton, J. M., Mammen, P. P. A., et al. (2018) · Science Advances · doi:10.1126/sciadv.aap9004 · Cited by 258
Pharmacological inhibition of DNA-PK stimulates Cas9-mediated genome editing
Robert, F., Barbeau, M., Éthier, S., Dostie, J., & Pelletier, J. (2015) · Genome Medicine · doi:10.1186/s13073-015-0215-6 · Cited by 255
“The sgRNA binds a DNA target site through sequence complementarity with the first approximately 20 5’ nucleotides whereas a 3’ aptameric domain is responsible for recruiting Cas9 to the genomic address [1].”
BackgroundGene silencing by CRISPR interference in mycobacteria
Choudhary, E., Thakur, P., Pareek, M., & Agarwal, N. (2015) · Nature Communications · doi:10.1038/ncomms7267 · Cited by 255
Emerging critical roles of Fe–S clusters in DNA replication and repair
Fuss, J. O., Tsai, C.-L., Ishida, J. P., & Tainer, J. A. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.01.018 · Cited by 257
Cancer-associated TERT promoter mutations abrogate telomerase silencing
Chiba, K., Johnson, J. Z., Vogan, J. M., Wagner, T., Boyle, J. M., & Hockemeyer, D. (2015) · eLife · doi:10.7554/elife.07918 · Cited by 251
“To address this question, we employed CAS9-(clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated systems 9) ( Jinek et al., 2012 ) mediated genome editing to derive human pluripotent stem cells (WIBR”
MethodOrmond, K. E., Mortlock, D. P., Scholes, D. T., Bombard, Y., Brody, L. C., Faucett, W. A., Garrison, N. A., Hercher, L., Isasi, R., Middleton, A., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.06.012 · Cited by 252
Cas9-mediated targeting of viral RNA in eukaryotic cells
Price, A. A., Sampson, T. R., Ratner, H. K., Grakoui, A., & Weiss, D. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422340112 · Cited by 250
Rewritable multi-event analog recording in bacterial and mammalian cells
Tang, W., & Liu, D. R. (2018) · Science · doi:10.1126/science.aap8992 · Cited by 260
“Both Cas9 nuclease and base editors make changes in cellular DNA in an efficient and programmable manner when complexedwith guideRNAs (11, 15).”
BackgroundCRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells
Min, Y.-L., Li, H., Rodriguez-Caycedo, C., Mireault, A. A., Huang, J., Shelton, J. M., McAnally, J. R., Amoasii, L., Mammen, P. P. A., Bassel-Duby, R., et al. (2019) · Science Advances · doi:10.1126/sciadv.aav4324 · Cited by 251
“(ii) sgRNAs are transcribed by RNA polymerase III and are likely to be confined to the nucleus (25, 26).”
Strzelec, M., Detka, J., Mieszczak, P., Sobocińska, M. K., & Majka, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1127704 · Cited by 233
Genome Editing with Engineered Nucleases in Plants
Osakabe, Y., & Osakabe, K. (2015) · Plant and Cell Physiology · doi:10.1093/pcp/pcu170 · Cited by 249
“SpCas9 is directed to the desired genomic target by a 20-nucleotide guide sequence in the gRNA, thus the CRISPR/Cas9 system is simple, easy to design and highly effective (Deveau et al. 2010, Deltcheva et al. 2011, Gasiunas et al. 2012, Jinek et al. 2012, Cong et al. 2013, Mali et al. 2013a).”
BackgroundGuide RNA Functional Modules Direct Cas9 Activity and Orthogonality
Briner, A. E., Donohoue, P. D., Gomaa, A. A., Selle, K., Slorach, E. M., Nye, C. H., Haurwitz, R. E., Beisel, C. L., May, A. P., & Barrangou, R. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.019 · Cited by 261
Efficient Genome Engineering of Toxoplasma gondii Using CRISPR/Cas9
Sidik, S. M., Hackett, C. G., Tran, F., Westwood, N. J., & Lourido, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100450 · Cited by 265
Adaptation in CRISPR-Cas Systems
Sternberg, S. H., Richter, H., Charpentier, E., & Qimron, U. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.01.030 · Cited by 253
Self-citationEfficient Gene Knockout in Goats Using CRISPR/Cas9 System
Ni, W., Qiao, J., Hu, S., Zhao, X., Regouski, M., Yang, M., Polejaeva, I. A., & Chen, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106718 · Cited by 249
“The CRISPR system, as an adaptive immune system in bacteria and archaea, uses small RNAs and CRISPR-associated (Cas) proteins to defend against invading viruses and plasmids [8,9].”
BackgroundButler, N. M., Atkins, P. A., Voytas, D. F., & Douches, D. S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0144591 · Cited by 249
Target-Specific Precision of CRISPR-Mediated Genome Editing
Chakrabarti, A. M., Henser-Brownhill, T., Monserrat, J., Poetsch, A. R., Luscombe, N. M., & Scaffidi, P. (2019) · Molecular Cell · doi:10.1016/j.molcel.2018.11.031 · Cited by 257
“Moreover, the recurrently inserted base was often homologous to nucleotide −4 from the PAM sequence, which is typically the nucleotide upstream of the cleavage site (Jinek et al., 2012) (89% of the commonest insertions at each target) (Fig.”
BackgroundMalzahn, A. A., Tang, X., Lee, K., Ren, Q., Sretenovic, S., Zhang, Y., Chen, H., Kang, M., Bao, Y., Zheng, X., et al. (2019) · BMC Biology · doi:10.1186/s12915-019-0629-5 · Cited by 245
CRISPR–Cas9 genome editing in human cells occurs via the Fanconi anemia pathway
Richardson, C. D., Kazane, K. R., Feng, S. J., Zelin, E., Bray, N. L., Schäfer, A. J., Floor, S. N., & Corn, J. E. (2018) · Nature Genetics · doi:10.1038/s41588-018-0174-0 · Cited by 242
Cho, S. W., Lee, J., Carroll, D., Kim, J.-S., & Lee, J. (2013) · Genetics · doi:10.1534/genetics.113.155853 · Cited by 250
“…short palindromic re-peat (CRISPR)-associated, Cas9-derived RNA-guided endonucleases (RGENs) enable targeted mutagenesis in cells and organisms (Cho et al. 2013a; Cong et al. 2013; DiCarlo et al. 2013; Gratz et al. 2013; Hwang et al. 2013; Jinek et al. 2012; Mali et al. 2013; Wang et al. 2012).”
BackgroundLv, L., Ren, Y.-L., Chen, J.-C., Wu, Q., & Chen, G.-Q. (2015) · Metabolic Engineering · doi:10.1016/j.ymben.2015.03.013 · Cited by 251
Potential pitfalls of CRISPR/Cas9‐mediated genome editing
Peng, R., Lin, G., & Li, J. (2016) · The FEBS Journal · doi:10.1111/febs.13586 · Cited by 213
Mammalian RAD52 Functions in Break-Induced Replication Repair of Collapsed DNA Replication Forks
Sotiriou, S. K., Kamileri, I., Lugli, N., Evangelou, K., Da-Ré, C., Huber, F., Padayachy, L., Tardy, S., Nicati, N. L., Barriot, S., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.10.038 · Cited by 249
Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9
Zhang, H.-X., Zhang, Y., & Yin, H. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.01.014 · Cited by 248
“The SpCas9 system requires a simple PAM sequence (NGG) as well as a target-specific crRNA and a trans-activating CRISPR RNA (tracrRNA), which could be fused into a single-guide RNA (sgRNA) for efficient genome editing.(24) Recently, SpCas9 variants that can recognize a broad PAM sequence, including NG, GAA, and GAT, h…”
MethodAird, E. J., Lovendahl, K. N., St. Martin, A., Harris, R. S., & Gordon, W. R. (2018) · Communications Biology · doi:10.1038/s42003-018-0054-2 · Cited by 250
Decaestecker, W., Buono, R. A., Pfeiffer, M. L., Vangheluwe, N., Jourquin, J., Karimi, M., Van Isterdael, G., Beeckman, T., Nowack, M. K., & Jacobs, T. B. (2019) · The Plant Cell · doi:10.1105/tpc.19.00454 · Cited by 258
“The most commonly used CRISPRsystem inplants isbasedon theCas9DNAendonuclease and its artificial CRISPR RNA, the guide RNA (gRNA; Jinek et al., 2012).”
MethodSingle-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy
Amoasii, L., Long, C., Li, H., Mireault, A. A., Shelton, J. M., Sanchez-Ortiz, E., McAnally, J. R., Bhattacharyya, S., Schmidt, F., Grimm, D., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan8081 · Cited by 247
Refining strategies to translate genome editing to the clinic
Cornu, T. I., Mussolino, C., & Cathomen, T. (2017) · Nature Medicine · doi:10.1038/nm.4313 · Cited by 252
Multiple Gene Repression in Cyanobacteria Using CRISPRi
Yao, L., Cengic, I., Anfelt, J., & Hudson, E. P. (2016) · ACS Synthetic Biology · doi:10.1021/acssynbio.5b00264 · Cited by 246
The Role of CRISPR-Cas Systems in Virulence of Pathogenic Bacteria
Louwen, R., Staals, R. H. J., Endtz, H. P., van Baarlen, P., & van der Oost, J. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00039-13 · Cited by 247
“Eventually, both DNA strands are cleaved at the active sites of Cas9 (red triangles) (20, 129, 130).”
BackgroundCandida albicans Gene Deletion with a Transient CRISPR-Cas9 System
Min, K., Ichikawa, Y., Woolford, C. A., & Mitchell, A. P. (2016) · mSphere · doi:10.1128/msphere.00130-16 · Cited by 247
“The RNA-guided endonuclease activity of Cas9 has been harnessed for an array of genome-editing applications in organisms ranging from fungi to plants and animals (5, 6).”
BackgroundIn Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges
Mout, R., Ray, M., Lee, Y.-W., Scaletti, F., & Rotello, V. M. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00057 · Cited by 243
Genome editing with the CRISPR‐Cas system: an art, ethics and global regulatory perspective
Zhang, D., Hussain, A., Manghwar, H., Xie, K., Xie, S., Zhao, S., Larkin, R. M., Qing, P., Jin, S., & Ding, F. (2020) · Plant Biotechnology Journal · doi:10.1111/pbi.13383 · Cited by 233
Konstantakos, V., Nentidis, A., Krithara, A., & Paliouras, G. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac192 · Cited by 241
Development of the CRISPR/Cas9 System for Targeted Gene Disruption in Aspergillus fumigatus
Fuller, K. K., Chen, S., Loros, J. J., & Dunlap, J. C. (2015) · Eukaryotic Cell · doi:10.1128/ec.00107-15 · Cited by 244
“Remarkably, and in just the past two years, the system derived 76 from Streptococcus pyogenes (17) has been simplified as a genomic engineering tool in diverse 77 eukaryotes such as mice and rats (18-21), plants (22, 23), and even fungi including, Saccharomyces 78 cerevisiae (24), Candida albicans (25), Trichoderma re…”
BackgroundTargeting non-coding RNAs with the CRISPR/Cas9 system in human cell lines
Ho, T.-T., Zhou, N., Huang, J., Koirala, P., Xu, M., Fung, R., Wu, F., & Mo, Y.-Y. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1198 · Cited by 244
The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells
Lee, C. M., Cradick, T. J., & Bao, G. (2016) · Molecular Therapy · doi:10.1038/mt.2016.8 · Cited by 246
“10 20 Current strategies to reduce CRISPR-Cas9 off-target effects include the use of partially inactivated Cas9 nickases 21,22 and a catalytically dead Cas9 fused to the FokI endonuclease domain, 23–25 both of which require the design and delivery of two gRNAs.”
Zhang, D., Wang, G., Yu, X., Wei, T., Farbiak, L., Johnson, L. T., Taylor, A. M., Xu, J., Hong, Y., Zhu, H., et al. (2022) · Nature Nanotechnology · doi:10.1038/s41565-022-01122-3 · Cited by 243
“We proceeded to (1) examine LNP distribution and penetration; (2) measure protein expression following translation of the delivered mRNA; (3) investigate the ECM and the infiltration of immune cells in the tumour microenvironment; (4) and compare the tumour growth in mice after 30 d treatment.”
MethodcrRNA and tracrRNA guide Cas9-mediated DNA interference in Streptococcus thermophilus
Karvelis, T., Gasiunas, G., Miksys, A., Barrangou, R., Horvath, P., & Siksnys, V. (2013) · RNA Biology · doi:10.4161/rna.24203 · Cited by 243
The no-SCAR (Scarless Cas9 Assisted Recombineering) system for genome editing in Escherichia coli
Reisch, C. R., & Prather, K. L. J. (2015) · Scientific Reports · doi:10.1038/srep15096 · Cited by 251
Evolutionary Ecology of Prokaryotic Immune Mechanisms
van Houte, S., Buckling, A., & Westra, E. R. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00011-16 · Cited by 245
“The tracrRNA remains bound to the processed crRNA and forms an essential component of the tracrRNA-crRNA-Cas9 effector complex (84).”
BackgroundXue, C., Zhao, J., Chen, L., Yang, S.-T., & Bai, F. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.01.007 · Cited by 244
Review of CRISPR/Cas9 sgRNA Design Tools
Cui, Y., Xu, J., Cheng, M., Liao, X., & Peng, S. (2018) · Interdisciplinary Sciences: Computational Life Sciences · doi:10.1007/s12539-018-0298-z · Cited by 245
Torres, R., Martin, M. C., Garcia, A., Cigudosa, J. C., Ramirez, J. C., & Rodriguez-Perales, S. (2014) · Nature Communications · doi:10.1038/ncomms4964 · Cited by 245
Magical mystery tour: MLO proteins in plant immunity and beyond
Acevedo‐Garcia, J., Kusch, S., & Panstruga, R. (2014) · New Phytologist · doi:10.1111/nph.12889 · Cited by 246
A multiplex CRISPR/Cas9 platform for fast and efficient editing of multiple genes in Arabidopsis
Zhang, Z., Mao, Y., Ha, S., Liu, W., Botella, J. R., & Zhu, J.-K. (2016) · Plant Cell Reports · doi:10.1007/s00299-015-1900-z · Cited by 245
“The engineered CRISPR/Cas system is composed of a single-stranded guide RNA (sgRNA) for target DNA recognition via base pairing, and a CRISPR-associated protein (Cas9) for DNA cleavage *3 bp upstream of the protospacer adjacent motif (PAM = ‘NGG’) (Jinek et al. 2012).”
CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo
Chang, H., Yi, B., Ma, R., Zhang, X., Zhao, H., & Xi, Y. (2016) · Scientific Reports · doi:10.1038/srep22312 · Cited by 242
O’Geen, H., Ren, C., Nicolet, C. M., Perez, A. A., Halmai, J., Le, V. M., Mackay, J. P., Farnham, P. J., & Segal, D. J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx578 · Cited by 242
Wang, Y., Wang, S., Chen, W., Song, L., Zhang, Y., Shen, Z., Yu, F., Li, M., & Ji, Q. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.01834-18 · Cited by 242
Partial DNA-guided Cas9 enables genome editing with reduced off-target activity
Yin, H., Song, C.-Q., Suresh, S., Kwan, S.-Y., Wu, Q., Walsh, S., Ding, J., Bogorad, R. L., Zhu, L. J., Wolfe, S. A., et al. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2559 · Cited by 240
He, Q., Yu, D., Bao, M., Korensky, G., Chen, J., Shin, M., Kim, J., Park, M., Qin, P., & Du, K. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112068 · Cited by 240
Recent trends in cancer therapy: A review on the current state of gene delivery
Yahya, E. B., & Alqadhi, A. M. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119087 · Cited by 235
Repurposing endogenous type I CRISPR-Cas systems for programmable gene repression
Luo, M. L., Mullis, A. S., Leenay, R. T., & Beisel, C. L. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku971 · Cited by 245
“Designed crRNAs directed the resulting catalytically dead Cas9 (dCas9) protein to bind specific promoters and coding regions, thereby modulating the recruitment of or extension by RNA polymerase (13–17).”
BackgroundInfluentialNeuroimmunity: Physiology and Pathology
Talbot, S., Foster, S. L., & Woolf, C. J. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055340 · Cited by 238
High-throughput mapping of regulatory DNA
Rajagopal, N., Srinivasan, S., Kooshesh, K., Guo, Y., Edwards, M. D., Banerjee, B., Syed, T., Emons, B. J. M., Gifford, D. K., & Sherwood, R. I. (2016) · Nature Biotechnology · doi:10.1038/nbt.3468 · Cited by 238
Subburaj, S., Chung, S. J., Lee, C., Ryu, S.-M., Kim, D. H., Kim, J.-S., Bae, S., & Lee, G.-J. (2016) · Plant Cell Reports · doi:10.1007/s00299-016-1937-7 · Cited by 237
Precision genome editing using CRISPR-Cas9 and linear repair templates in C. elegans
Paix, A., Folkmann, A., & Seydoux, G. (2017) · Methods · doi:10.1016/j.ymeth.2017.03.023 · Cited by 256
Wan, D.-Y., Guo, Y., Cheng, Y., Hu, Y., Xiao, S., Wang, Y., & Wen, Y.-Q. (2020) · Horticulture Research · doi:10.1038/s41438-020-0339-8 · Cited by 228
PAM-less plant genome editing using a CRISPR–SpRY toolbox
Ren, Q., Sretenovic, S., Liu, S., Tang, X., Huang, L., He, Y., Liu, L., Guo, Y., Zhong, Z., Liu, G., et al. (2021) · Nature Plants · doi:10.1038/s41477-020-00827-4 · Cited by 234
Advanced genetic tools for plant biotechnology
Liu, W., Yuan, J. S., & Stewart Jr, C. N. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3583 · Cited by 234
AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma
Chow, R. D., Guzman, C. D., Wang, G., Schmidt, F., Youngblood, M. W., Ye, L., Errami, Y., Dong, M. B., Martinez, M. A., Zhang, S., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4620 · Cited by 241
Major bacterial lineages are essentially devoid of CRISPR-Cas viral defence systems
Burstein, D., Sun, C. L., Brown, C. T., Sharon, I., Anantharaman, K., Probst, A. J., Thomas, B. C., & Banfield, J. F. (2016) · Nature Communications · doi:10.1038/ncomms10613 · Cited by 246
Transgene Expression in Microalgae—From Tools to Applications
Doron, L., Segal, N., & Shapira, M. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.00505 · Cited by 235
A geminivirus-based guide RNA delivery system for CRISPR/Cas9 mediated plant genome editing
Yin, K., Han, T., Liu, G., Chen, T., Wang, Y., Yu, A. Y. L., & Liu, Y. (2015) · Scientific Reports · doi:10.1038/srep14926 · Cited by 235
“To overcome this problem, future modifications may include: (1) finding a shorter version of the U6 promoter that significantly reduces the length of the promoter while retaining its activity; (2) using ribozyme or tRNA to help express multiple gRNAs under the same modified U6 promoter40,41; (3) using other promoters…”
MethodActivities and specificities of CRISPR/Cas9 and Cas12a nucleases for targeted mutagenesis in maize
Lee, K., Zhang, Y., Kleinstiver, B. P., Guo, J. A., Aryee, M. J., Miller, J., Malzahn, A., Zarecor, S., Lawrence‐Dill, C. J., Joung, J. K., et al. (2019) · Plant Biotechnology Journal · doi:10.1111/pbi.12982 · Cited by 232
“For genome editing applications, a CRISPR-Cas9 system consists of two essential components: a Cas9 effector protein, which induces blunt-end double strand breaks (DSBs), and a single guide RNA (sgRNA), which contains an approximately 20nt targeting sequence (Hsu et al., 2014; Jinek et al., 2012).”
BackgroundThe CRISPR–Cas toolbox for analytical and diagnostic assay development
Tang, Y., Gao, L., Feng, W., Guo, C., Yang, Q., Li, F., & Le, X. C. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00098e · Cited by 238
Shen, C., Que, Z., Xia, Y., Tang, N., Li, D., He, R., & Cao, M. (2017) · Journal of Plant Biology · doi:10.1007/s12374-016-0400-1 · Cited by 234
Methods and Applications of CRISPR-Mediated Base Editing in Eukaryotic Genomes
Hess, G. T., Tycko, J., Yao, D., & Bassik, M. C. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.029 · Cited by 234
“…work has been done to reveal the underlyingmechanisms of this process (Deltcheva et al., 2011; Gasiunas et al., 2012; Jiang and Doudna, 2017; Jinek et al., 2012; Nishimasu et al., 2014) and enable its transfer to eukaryotic systems (Cong et al., 2013; Jinek et al., 2013; Mali et al., 2013).”
InfluentialDramatic Enhancement of Genome Editing by CRISPR/Cas9 Through Improved Guide RNA Design
Farboud, B., & Meyer, B. J. (2015) · Genetics · doi:10.1534/genetics.115.175166 · Cited by 246
“…to generate random insertions and deletions or repaired precisely by homology-directed repair (HDR) templated from exogenous DNA to generate custom-designed insertions, deletions, or substitutions (Gasiunas et al. 2012; Jinek et al. 2012; Cong et al. 2013; Jinek et al. 2013; Mali et al. 2013).”
BackgroundInfluentialKazlauskiene, M., Tamulaitis, G., Kostiuk, G., Venclovas, Č., & Siksnys, V. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.03.024 · Cited by 265
Metadata
- Authors
- Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E.
- Affiliations
- Howard Hughes Medical Institute (HHMI), University of California, Berkeley, CA 94720, USA.
- University of Vienna (AT)
- Umeå Centre for Microbial Research (SE)
- University of California, Berkeley (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Chylinski, Krzysztof
- Doudna, Jennifer A.
- Charpentier, Emmanuelle
- Venue
- Science
- Published
- 2012-08-17
- Volume
- 337
- Issue
- 6096
- Pages
- 816-821
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC6286148
- OpenAlex
- W2045435533
- Semantic Scholar
- 68d962effe5520777791bd6ec8ffa4b963ba4f38
- Cited by
- 17,116
- References
- 48
- Citations by year
- 2026: 1083 · 2025: 1512 · 2024: 1602 · 2023: 1572 · 2022: 1795 · 2021: 1793 · 2020: 1577 · 2019: 1344 · 2018: 1255 · 2017: 1141 · 2016: 1018 · 2015: 680 · 2014: 467 · 2013: 231 · 2012: 29
- FWCI
- 180.75
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR/Cas9, sequence-specific DNA cleavage, DNA double-strand breaks
- MeSH terms
- Bacteriophages, Base Sequence, Molecular Sequence Data, Nucleic Acid Conformation, Plasmids, RNA, Streptococcus pyogenes, Deoxyribonucleases, Type II Site-Specific, DNA Cleavage, DNA Breaks, Double-Stranded, Inverted Repeat Sequences
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.